These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8828938)

  • 1. Contact lens induced conjunctivitis: a model of human ocular inflammation.
    Friedlaender MH
    CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal eye drops for ocular allergy.
    Schwab IR
    West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163
    [No Abstract]   [Full Text] [Related]  

  • 3. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac for seasonal allergic conjunctivitis.
    Med Lett Drugs Ther; 1993 Sep; 35(905):88-9. PubMed ID: 8361452
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.
    Raizman MB
    Clin Ther; 1995; 17(5):882-90. PubMed ID: 8595640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
    Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
    Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions.
    Donnenfeld ED; Selkin BA; Perry HD; Moadel K; Selkin GT; Cohen AJ; Sperber LT
    Ophthalmology; 1995 Jun; 102(6):979-84. PubMed ID: 7777307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
    Tauber J; Raizman MB; Ostrov CS; Laibovitz RA; Abelson MB; Betts JG; Koester JM; Gill D; Schaich L
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):137-45. PubMed ID: 9572539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Ballas Z; Blumenthal M; Tinkelman DG; Kriz R; Rupp G
    Surv Ophthalmol; 1993; 38 Suppl():141-8. PubMed ID: 8236005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study Group.
    Kaiser PK; Pineda R
    Ophthalmology; 1997 Aug; 104(8):1353-9. PubMed ID: 9261326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical update: new medications for ocular allergy.
    Trayner EM
    N J Med; 1994 Sep; 91(9):607. PubMed ID: 7970285
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
    Yaylali V; Demirlenk I; Tatlipinar S; Ozbay D; Esme A; Yildirim C; Ozden S
    Acta Ophthalmol Scand; 2003 Aug; 81(4):378-82. PubMed ID: 12859265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketorolac tromethamine in the maintenance of intraoperative mydriasis.
    Gupta VP; Dhaliwal U; Prasad N
    Ophthalmic Surg Lasers; 1997 Sep; 28(9):731-8. PubMed ID: 9304635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.